Your browser doesn't support javascript.
loading
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.
Hiraoka, Atsushi; Kumada, Takashi; Kariyama, Kazuya; Toyoda, Hidenori; Yasuda, Satoshi; Tsuji, Kunihiko; Hatanaka, Takeshi; Kakizaki, Satoru; Naganuma, Atsushi; Ishikawa, Toru; Tada, Toshifumi; Takaguchi, Koichi; Itobayashi, Ei; Shimada, Noritomo; Shibata, Hiroshi; Tanaka, Takaaki; Tsutsui, Akemi; Nagano, Takuya; Imai, Michitaka; Nakamura, Shinichiro; Nouso, Kazuhiro.
Afiliação
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
  • Kumada T; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Kariyama K; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Toyoda H; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Yasuda S; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Tsuji K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Hatanaka T; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Kakizaki S; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Naganuma A; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Ishikawa T; Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Tada T; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Takaguchi K; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
  • Itobayashi E; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Shimada N; Department of Gastroenterology, Gunma Saiseikai Maebashi Hospital, Gunma, Japan.
  • Shibata H; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Tanaka T; Department of Clinical Research, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
  • Tsutsui A; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Nagano T; Department of Gastroenterology, National Hospital Organization Takasaki General Medical Center, Takasaki, Japan.
  • Imai M; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
  • Nakamura S; Department of Gastroenterology, Saiseikai Niigata Hospital, Niigata, Japan.
  • Nouso K; Real-life Practice Experts for HCC (RELPEC) Study Group, Matsuyama, Japan.
Oncology ; 100(2): 65-73, 2022.
Article em En | MEDLINE | ID: mdl-34844247

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Bilirrubina / Protrombina / Biomarcadores / Alfa-Fetoproteínas / Carcinoma Hepatocelular / Albuminas / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Precursores de Proteínas / Bilirrubina / Protrombina / Biomarcadores / Alfa-Fetoproteínas / Carcinoma Hepatocelular / Albuminas / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Oncology Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça